Abstract
The pharmaceuticals bisoprolol (BIS), sotalol (SOT), and ranitidine (RAN) are among the most consumed pharmaceuticals worldwide and are frequently detected in different aquatic ecosystems. However, very few ecotoxicity data are available in the literature for them. To help fill these data gaps, toxicity tests with the algae Raphidocelis subcapitata, the macrophyte Lemna minor, the cnidarian Hydra attenuata, the crustacean Daphnia similis, and the fish Danio rerio were performed for assessing the ecotoxicity of these pharmaceuticals. Standard, as well as non-standard endpoint, was evaluated, including the locomotor behavior of D. rerio larvae. Results obtained for SOT and RAN showed that acute adverse effects are not expected to occur on aquatic organisms at the concentrations at which these pharmaceuticals are usually found in fresh surface waters. On the other hand, BIS was classified as hazardous to the environment in the acute III category. Locomotor behavior of D. rerio larvae was not affected by BIS and RAN. A disturbance on the total swimming distance at the dark cycle was observed only for larvae exposed to the highest test concentration of 500 mg L−1 of SOT. D. similis reproduction was affected by BIS with an EC10 of 3.6 (0.1–34.0) mg L−1. A risk quotient (RQ) of 0.04 was calculated for BIS in fresh surface water, considering a worst-case scenario. To the best of our knowledge, this study presents the first chronic toxicity data with BIS on non-target organisms.
Similar content being viewed by others
References
Andrade TS, Henriques JF, Almeida AR, Machado AL, Koba O, Giang PT, Soares AMVM, Domingues I (2016) Carbendazim exposure induces developmental, biochemical and behavioural disturbance in zebrafish embryos. Aquat Toxicol 170:390–399. https://doi.org/10.1016/j.aquatox.2015.11.017
Associação Brasileira de Normas Técnicas - ABNT NBR 12713 (2016) Aquatic ecotoxicology-acute toxicity-bioassay methodology with Daphnia spp (Crustacea, Cladocera). Brazilian Association of Technique Standards, São Paulo, p 27
Associação Brasileira de Normas Técnicas - ABNT NBR 12648 (2018) Aquatic ecotoxicology–chronic toxicity–test with algae (Chlorophyceae). Brazilian Association of Technique Standards, São Paulo, p 27
Barata C, Baird DJ, Nogueira AJA, Soares AMVM, Riva MC (2006) Toxicity of binary mixtures of metals and pyrethroid insecticides to Daphnia magna Straus. Implications for multi-substance risks assessment. Aquat Toxicol 78:1–14. https://doi.org/10.1016/j.aquatox.2006.01.013
Bergheim M, Gieré R, Kümmerer K (2012) Biodegradability and ecotoxicity of tramadol, ranitidine and their photoderivatives in the aquatic environment. Environ Sci Pollut Res 19:72–85. https://doi.org/10.1007/s11356-011-0536-y
Besse J-P, Garric J (2008) Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation. Toxicol Lett 176:104–123. https://doi.org/10.1016/j.toxlet.2007.10.012
Bojić D, Momčilović M, Milenković D, Mitrović J, Banković P, Velinov N, Nikolić G (2015) Characterization of a low cost Lagenaria vulgaris based carbon for ranitidine removal from aqueous solutions. Arab J Chem 10:956–964. https://doi.org/10.1016/j.arabjc.2014.12.018
Bühring KU, Sailer H, Faro HP, Leopold G, Pabst J, Garbe A (1986) Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans. J Cardiovasc Pharmacol 8(11):S21–S28. https://doi.org/10.1097/00005344-198511001-00004
Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E (2006) Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40:357–363. https://doi.org/10.1021/es050991m
Domènech X, Ribera M, Peral J (2011) Assessment of pharmaceuticals fate in a model environment. Water Air Soil Poll 218:413–422. https://doi.org/10.1007/s11270-010-0655-y
DSM GROUP (2014) Russian Pharmaceutical market. Available at: https://dsm.ru/docs/analytics/dsm_report_2014_20_05_1.pdf. Accessed on April 4th 2019
Escher BI, Bramaz N, Richter M, Lienert J (2006) Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environ Sci Technol 40:7402–7408. https://doi.org/10.1021/es052572v
European Commission (2003) Technical guidance document on risk assessment-part II-environmental risk assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. European Union
European Commission (2011) Technical guidance for deriving environmental quality standards. Common Implementation Strategy for the Water Framework Directive (2000/60/EC). Guidance Document No. 27. European Union. https://doi.org/10.2779/43816
European Medicines Agency - EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use. Committee for medicinal products for human use. EMEA/CHMP/SWP/4447/00 European Medicines Agency, London, United Kingdom. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-environmental-risk-assessment-medicinal-products-human-use-firstversion_en.pdf. Accessed 15 Jan 2019
Feiner M, Laforsch C, Letzel T, Geist J (2014) Sublethal effects of the beta-blocker sotalol at environmentally relevant concentrations on the New Zealand mudsnail Potamopyrgus antipodarum. Environ Toxicol Chem 33(11):2510–2515. https://doi.org/10.1002/etc.2699
Ferrari F, Gallipoli A, Balderacchi M, Ulaszewska MM, Capri E, Trevisan M (2011) Exposure of the main Italian river basin to pharmaceuticals. J Toxicol 2011:989270, 11p. https://doi.org/10.1155/2011/989270
Ferrer P, Ballarín E, Sabaté M, Petri H, Goh KL, Yeboa S, Solari P, Ibáñez L (2011) Drug consumption databases in Europe - Master document WP2 Framework for pharmacoepidemiological studies and WG3 Drug utilization data. Barcelona, Spain 190p. Available at: http://www.imi-protect.eu/documents/DUinventory_2011_6_WORD97-2003.pdf. Accessed 10 Apr 2019
Gabet-Giraud V, Miège C, Choubert JM, Ruel SM, Coquery M (2010) Occurrence and removal of estrogens ad beta blockers by various processes in wastewater treatment plants. Sci Total Environ 408:4257–4269. https://doi.org/10.1016/j.scitotenv.2010.05.023
Ginebreda A, Muñoz I, de Alda ML, Brix R, López-Doval J, Barceló D (2010) Environmental risk assessment of pharmaceuticals in river: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ Int 36:153–162. https://doi.org/10.1016/j.envint.2009.10.003
Godoy AA, Kummrow F (2017) What do we know about the ecotoxicology of pharmaceutical and personal care product mixtures? A critical review. Crit Rev Env Sci Tec 47(16):1453–1496. https://doi.org/10.1080/10643389.2017.1370991
Godoy AA, Kummrow F, Pamplin PAZ (2015) Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment–a review. Chemosphere 138:281–291. https://doi.org/10.1016/j.chemosphere.2015.06.024
Godoy AA, Domingues I, Nogueira AJA, Kummrow F (2018) Ecotoxicological effects, water quality standards and risk assessment for the anti-diabetic metformin. Environ Pollut 243:534–542. https://doi.org/10.1016/j.envpol.2018.09.031
Godoy AA, de Oliveira AC, Silva JGM, Azevedo CCJ, Domingues I, Nogueira AJA, Kummrow F (2019) Single and mixture toxicity of four pharmaceuticals of environmental concern to aquatic organisms, including a behavioral assessment. Chemosphere 235:373–382. https://doi.org/10.1016/j.chemosphere.2019.06.200
Gonçalves CMO, Sousa MAD, Alpendurada MFPSPM (2013) Analysis of acid, basic and neutral pharmaceuticals in river waters: clean-up by 1°, 2° amino anion exchange and enrichment using a hydrophilic adsorbent. Int J Environ Anal Chem 93:1–22. https://doi.org/10.1080/03067319.2012.702272
Gros M, Rodríguez-Mozaz S, Barceló D (2012) Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 1248:104–121. https://doi.org/10.1016/j.chroma.2012.05.084
Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ (2008) Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42:5807–5813. https://doi.org/10.1021/es8005173
Guo J, Boxall A, Selby K (2015) Do pharmaceuticals pose a threat to primary producers? Crit Rev Environ Sci Technol 45(23):2565–2610. https://doi.org/10.1080/10643389.2015.1061873
Hernando MD, Petrovic M, Fernández-Alba AR, Barceló D (2004) Analysis by chromatography-electrospray ionization tandem mass spectrometry and acute toxicity evaluation for β-blockers and lipid-regulating agents in wastewater samples. J Chromatogr A 1046:133–140. https://doi.org/10.1016/j.chroma.2004.06.102
Holdway DA (2005) Hydra population reproduction toxicity test method. In: Blaise C, Férard J-F (Eds.). Small-scale freshwater toxicity investigations. Springer, 395–411. DOI: https://doi.org/10.1007/1-4020-3120-3
Houtman CJ, Broek RT, de Jong K, Pieterse B, Kroesbergen J (2013) A multicomponent snapshot of pharmaceuticals and pesticides in the river Meuse basin. Environ Toxicol Chem 32(11):2449–2459. https://doi.org/10.1002/etc.2351
Huerta-Fontela M, Galceran MT, Ventura F (2010) Fast liquid chromatography–quadrupole linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources. J Chromatogr A 1217:4212–4222. https://doi.org/10.1016/j.chroma.2009.11.007
Huerta-Fontela M, Galceran MT, Ventura F (2011) Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 45:1432–1442. https://doi.org/10.1016/j.watres.2010.10.036
IMS Institute for Healthcare Informatics (2015) Global medicines use in 2020–outlook and implications. Available at: https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/global-medicines-use-in-2020. Accessed on April 12th 2019
Isidori M, Parrella A, Pistillo P, Temussi F (2009) Effects of ranitidine and its photoderivatives in the aquatic environment. Environ Int 35:821–825. https://doi.org/10.1016/j.envint.2008.12.002
Jauković ZD, Grujić SD, Vasiljević TM, Petrović SD (2014) Cardiovascular drugs in environmental waters and wastewaters: method optimization and real sample analysis. J AOAC Int 97(4):1167–1174. https://doi.org/10.5740/jaoacint.12-121
Jonker MJ, Svendsen C, Bedaux JJM, Bongers M, Kammenga JE (2005) Significance testing of synergistic/antagonistic, dose level-dependent, or dose ratio-dependent effects in mixture dose-response analysis. Environ Toxicol Chem 24(10):2701–2713. https://doi.org/10.1897/04-431R.1
Kasagić-Vujanović I, Stojanović BJ, Ivanović D (2017) Monitoring of bisoprolol fumarate stability under different stress conditions. In: Badnjević A (ed) CMBEBIH 2017. IFMBE proceedings, vol. 62. Springer, Singapore. https://doi.org/10.1007/978-981-10-4166-2_64
Klančar A, Trontelj J, Kristl A, Justin MZ, Rošcar R (2016) Levels of pharmaceuticals in Slovene municipal and hospital wastewaters: a preliminary study. Arh Hig Rada Toksikol 67:106–115. https://doi.org/10.1515/aiht-2016-67-2727
Kot-Wasik A, Jakimska A, Śliwka-Kaszyńska M (2016) Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants. Environ Monit Assess 188:661, 13p–613. https://doi.org/10.1007/s10661-016-5637-0
Lahti M, Oikari A (2011) Microbial transformation of pharmaceuticals naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments. Arch Environ Contam Toxicol 61:202–210. https://doi.org/10.1007/s00244-010-9622-2
Lara-Martín PA, González-Mazo E, Petrovic M, Barceló D, Brownawell BJ (2014) Occurrence, distribution and partitioning of nonionic surfactants and pharmaceuticals in the urbanized Long Island Sound Estuary (NY). Mar Pollut Bull 85:710–719. https://doi.org/10.1016/j.marpolbul.2014.01.022
Larsson DGJ, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148:751–755. https://doi.org/10.1016/j.jhazmat.2007.07.008
Lee H-B, Sarafin K, Peart TE (2007) Determination of β-blockers and β2-agonists in sewage by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A 1148:158–167. https://doi.org/10.1016/j.chroma.2007.03.024
Lindim C, van Gils J, Georgieva D, Mekenyan O, Cousins IT (2016) Evaluation of human pharmaceutical emissions and concentrations in Swedish river basins. Sci Total Environ 572:508–519. https://doi.org/10.1016/j.scitotenv.2016.08.074
Loos R, Carvalho R, António DC, Comero S, Locoro G, Tavazzi S, Paracchini B, Ghiani M, Lettieri T, Blaha L, Jarosova B, Voorspoels S, Servaes K, Haglund P, Fick J, Lindberg RH, Schwesig D, Gawlik BM (2013) EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water Res 47:6475–6487. https://doi.org/10.1016/j.watres.2013.08.024
López-Roldán R, de Alda ML, Gros M, Petrovic M, Martín-Alonso J, Barceló D (2010) Advanced monitoring of pharmaceuticals and estrogens in the Llobregat river basin (Spain) by liquid chromatography–triple quadrupole-tandem mass spectrometry in combination with ultra-performance liquid chromatography–time of flight-mass spectrometry. Chemosphere 80:1337–1344. https://doi.org/10.1016/j.chemosphere.2010.06.042
López-Serna R, Jurado A, Vázquez-Suñé E, Carrera J, Petrović M, Barceló D (2013) Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain. Environ Pollut 174:305–315. https://doi.org/10.1016/j.envpol.2012.11.022
Maszkowska J, Stolte S, Kumirska J, Łukaszewicz P, Mioduszewska K, Puckowski A, Caban M, Wagil M, Stepnowski P, Białk-Bielińska A (2014a) Beta-blockers in the environment: part I. Mobility and hydrolysis study. Sci Total Environ 493:1112–1121. https://doi.org/10.1016/j.scitotenv.2014.06.023
Maszkowska J, Stolte S, Kumirska J, Łukaszewicz P, Mioduszewska K, Puckowski A, Caban M, Wagil M, Stepnowski P, Białk-Bielińska A (2014b) Beta-blockers in the environment: part II. Ecotoxicity study. Sci Total Environ 493:1122–1126. https://doi.org/10.1016/j.scitotenv.2014.06.039
Maurer M, Escher BI, Richle P, Schaffner C, Alder AC (2007) Elimination of β-blockers in sewage treatment plants. Water Res 41:1614–1622. https://doi.org/10.1016/j.watres.2007.01.004
Meador JP, Yeh A, Young G, Gallagher EP (2016) Contaminants of emerging concern in a large temperate estuary. Environ Pollut 213:254–267. https://doi.org/10.1016/j.envpol.2016.01.088
Minguez L, Pedelucq J, Farcy E, Ballandonne C, Budzinski H, Halm-Lemeille M-P (2014) Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France. Environ Sci Pollut Res 23(6):4992–5001. https://doi.org/10.1007/s11356-014-3662-5
Oliveira TS, Murphy M, Mendola N, Wong V, Carlson D, Waring L (2015) Characterization of pharmaceuticals and personal care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS. Sci Total Environ 518-519:459–478. https://doi.org/10.1016/j.scitotenv.2015.02.104
Oliveira R, Grisolia CK, Monteiro MS, Soares AMVM, Domingues I (2016) Multilevel assessment of ivermectin effects using different zebrafish life stages. Comp Biochem Phys C 187:50–61. https://doi.org/10.1016/j.cbpc.2016.04.004
Oosterhuis M, Sacher F, ter Laak TL (2013) Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. Sci Total Environ 442:380–388. https://doi.org/10.1016/j.scitotenv.2012.10.046
Organisation for Economic Cooperation and Development (OECD) (2001) Test no. 201: freshwater alga and cyanobacteria, growth inhibition test. OECD Guidel. Test. Chem. DOI: https://doi.org/10.1787/9789264069923-en
Organisation for Economic Cooperation and Development (OECD) (2002) Harmonised integrated classification system for human health and environmental hazards of chemical substances and mixtures. OECD series on testing and assessment. France, Paris. https://doi.org/10.1787/9789264078475-en
Organisation for Economic Cooperation and Development (OECD) 2004. . Test no. 202: Daphnia sp. Acute immobilisation test. OECD Guidel. Test. Chem. DOI: https://doi.org/10.1787/9789264069947-en
Organisation for Economic Cooperation and Development (OECD) 2006. Test no. 221: Lemna sp. Growth inhibition test. .OECD Guidel. Test. Chem. DOI: https://doi.org/10.1787/9789264016194-em
Organisation for Economic Cooperation and Development (OECD) 2012. Test no. 211: Daphnia magna reproduction test. OECD Guidel. Test. Chem. DOI: https://doi.org/10.1787/9789264185203-en
Organisation for Economic Cooperation and Development (OECD) 2013. . Test no. 236: Fish Embryo Acute Toxicity (FET) Test. OECD Guid. Test. Chem. DOI: https://doi.org/10.1787/9789264203709-em
Palmgrén JJ, Mönkkönen J, Korjamo T, Hassinen A, Auriola S (2006) Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur J Pharm Biopharm 64:369–378. https://doi.org/10.1016/j.ejpb.2006.06.005
Petrović M, Škrbić B, Živančev J, Ferrando-Climent L, Barceló D (2014) Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole–linear ion trap in different types of water in Serbia. Sci Total Environ 468-469:415–428. https://doi.org/10.1016/j.scitotenv.2013.08.079
Piram A, Salvador A, Verne C, Herbreteau B, Faure R (2008) Photolysis of β-blockers in environmental waters. Chemosphere 73:1265–1271. https://doi.org/10.1016/j.chemosphere.2008.07.018
PubChem U.S. National library of medicine. National Center for Biotechnology Information Available at: https://pubchem.ncbi.nlm.nih.gov/. Accessed 6 June 2019
Radjenović J, Petrovic M, Barceló D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387:1365–1377. https://doi.org/10.1007/s00216-006-0883-6
Radjenović J, Petrović M, Barceló D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43:831–841. https://doi.org/10.1016/j.watres.2008.11.043
Reh R, Licha T, Geyer T, Nödler K, Sauter M (2013) Occurrence and spatial distribution of organic micro-pollutants in a complex hydrogeological karst system during low flow and high flow periods, results of a two-year study. Sci Total Environ 443:438–445. https://doi.org/10.1016/j.scitotenv.2012.11.005
Richmond EK, Rosi EJ, Walters DM, Fick J, Hamilton SK, Brodin T, Sundelin A, Grace MR (2018) A diverse suit of pharmaceuticals contaminates stream and riparian food webs. Nat Commun 9:4491. https://doi.org/10.1038/s41467-018-06822-w
Ruff M, Mueller MS, Loos M, Singer HP (2015) Quantitative target and systematic non-target analysis of polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry–identification of unknown sources and compounds. Water Res 87:145–154. https://doi.org/10.1016/j.watres.2015.09.017
Sampson KJ, Kass RS (2012). Antiarrhythmic drugs (chapter 29). In: Brunton LL, Chabner BA, Knollmann BC (org.). Goodman & Gilman’s pharmacological basis of therapeutic, 12th edition. The McGraw-Hill Companies, Inc., New York 10020. ISBN: 0071624422/9780071624428
Sanches ALM, Daam MA, Freitas EC, Godoy AA, Meireles G, Almeida AR, Domingues I, Espíndola ELG (2018) Lethal and sublethal toxicity of abamectin and difeconazole (individually and in mixture) to early life stages of zebrafish. Chemosphere 210:531–538. https://doi.org/10.1016/j.chemosphere.2018.07.027
Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175:45–95. https://doi.org/10.1016/j.jhazmat.2009.10.100
Santos LHMLM, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, Barceló D, Montenegro MCBSM (2013) Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci Total Environ 461-462:302–316. https://doi.org/10.1016/j.scitotenv.2013.04.077
Savci S (2013) Biosorption of ranitidine onto live activated sludge. Asian J Chem 25(6):3175–3178
Scheurer M, Ramil M, Metcalfe CD, Groh S, Ternes TA (2010) The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal Bional Chem 396:845–856. https://doi.org/10.1007/s00216-009-3225-7
Scott GR, Sloman KA (2004) The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity. Aquat Toxicol 68:369–392. https://doi.org/10.1016/j.aquatox.2004.03.016
Stankiewicz A, Giebułtowicz J, Stankiewicz U, Wroczyński P, Nałęcz-Jawecki G (2015) Determination of selected cardiovascular active compounds in environmental aquatic samples-methods and results, a review of global publications from the last 10 years. Chemosphere 138:642–656. https://doi.org/10.1016/j.chemosphere.2015.07.056
Steele SL, Yang X, Debiais-Thibaud M, Schwerte T, Pelster B, Ekker M, Tiberi M, Perry SF (2011) In vivo and in vitro assessment of cardiac β-adrenergic receptors in larval zebrafish (Danio rerio). J Exp Biol 214:1445–1457. https://doi.org/10.1242/jeb.052803
Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32(11):3245–3260
Trottier S, Blaise C, Kusui T, Johnson EM (1997) Acute toxicity assessment of aqueous samples using a microplate-based Hydra attenuata assay. Environ Toxicol 12(3):265–271. https://doi.org/10.1002/(SICI)1098-2256(1997)12:3<265::AID-TOX10>3.0.CO;2e9
UBA–Umwelt Bundesamt (2013) Pharmaceuticals in the environment–a first compilation of German monitoring data. Available at: https://www.umweltbundesamt.de. Acessed on March 11th 2019
UBA-Umwelt Bundesamt database (2019) Pharmaceuticals in the environment. Available at: https://www.umweltbundesamt.de/en/database-pharmaceuticals-in-the-environment-0. Accessed on April 8th 2019
Vediappan K, Lee CW (2011) Eletrochemical approaches for the determination of ranitidine drug reaction mechanism. Curr Appl Phys 11:995–1000. https://doi.org/10.1016/j.cap.2011.01.007
Verlicchi P, Aukidy MA, Galletti A, Petrovic M, Barceló D (2012) Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 430:109–118. https://doi.org/10.1016/j.scitotenv.2012.04.055
Wang Z, Nishimura Y, Shimada Y, Umemoto N, Hirano M, Zang L, Oka T, Sakamoto C, Kuroyanagi J, Tanaka T (2009) Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation. Gene 446:18–27. https://doi.org/10.1016/j.gene.2009.06.005
Webb SF (2001) A data-based perspective on the environmental risk assessment of human pharmaceuticals I–collation of available ecotoxicity data (chapter 15). In: Kümmerer K (ed) Pharmaceuticals in the environment – sources, fate, effects and risks, 1st edn. Springer-Verlag, Berlin Heidelberg, Heidelberg, pp 175–200 ISBN: 978-3-662-04636-4
Westfall TC, Westfall DP (2012) Adrenergic agonists and antagonists (chapter 12). In: Brunton LL, Chabner BA, Knollmann BC (org.). Goodman & Gilman’s pharmacological basis of therapeutic, 12th edition. The McGraw-Hill Companies, Inc., New York 10020. ISBN: 0071624422/9780071624428
Funding
The support was given by the Sandwich Doctorate scholarship attributed to M. Sc. Aline Andrade Godoy by CAPES (88881.132858/2016-01). The authors acknowledge the Laboratory of Ecotoxicology and Genotoxicity (LAEG), Unicamp, SP, Brazil, especially Professor Dra. Gisela de Aragão Umbuzeiro, as well as the facility of the Department of Biology of University of Aveiro, Portugal, for providing technical and material support. Thanks are due for the financial support of CESAM (UID/AMB/50017/2019), by FCT/MCTES through national funds. Inês Domingues is funded by national funds (OE), through FCT–Fundação para a Ciência e a Tecnologia, I.P., in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of the article 23 of the Decree-Law 57/2016 on August 29, changed by Law 57/2017 on July 19.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Philippe Garrigues
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Godoy, A.A., Domingues, I., de Carvalho, L.B. et al. Assessment of the ecotoxicity of the pharmaceuticals bisoprolol, sotalol, and ranitidine using standard and behavioral endpoints. Environ Sci Pollut Res 27, 5469–5481 (2020). https://doi.org/10.1007/s11356-019-07322-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-019-07322-0